Moncef Slaoui
CIK: 0001712369
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 22, 2026PCVX
Vaxcyte, Inc.
Award(A)DirectStock Option (right to buy)
26.1K shares- - Jun 5, 2026ARCT
Arcturus Therapeutics Holdings Inc.
Award(A)DirectStock option (right to buy)
15K shares- - Jun 9, 2025ARCT
Arcturus Therapeutics Holdings Inc.
Award(A)DirectStock option (right to buy)
15K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 22, 2026 |  PCVX Vaxcyte, Inc. | Award(A) Stock Option (right to buy) | 26,061 | - | - | Direct |
| Jun 5, 2026 |  ARCT Arcturus Therapeutics Holdings Inc. | Award(A) Stock option (right to buy) | 15,000 | - | - | Direct |
| Jun 9, 2025 | ARCT Arcturus Therapeutics Holdings Inc. | Award(A) Stock option (right to buy) | 15,000 | - | - | Direct |
1-3 of 3 transactions
About Slaoui Moncef
Slaoui Moncef (SEC CIK 0001712369) files insider reports with the SEC as Director of Vaxcyte, Inc. (PCVX) and Director of Arcturus Therapeutics Holdings Inc. (ARCT).
Signal8 holds 4 ownership filings by Slaoui Moncef (1 Form 3, 3 Form 4), filed between Jun 11, 2025 and Jun 23, 2026. Those filings report 3 transactions, from Jun 9, 2025 to Jun 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Slaoui Moncef's filings is in SAN DIEGO, CA.
Recent filings by Slaoui Moncef
Other insiders filing for Vaxcyte, Inc. (PCVX)
- Wassil Jim, EVP, Chief Scientific Ofc, COO
- Cowan Elvia, SVP, Finance & CAO
- PICKERING GRANT, CHIEF EXECUTIVE OFFICER
- GUGGENHIME ANDREW, PRESIDENT AND CFO
- Dhaliwal Harpreet S., Chief Technical Ops Officer
- Jodar Luis, Chief Medical Officer